-Hiromitsu Kumada Researcher Activity Profile

Research Author Detailed Information 

Hiromitsu Kumada Publication Rate By Year

Hiromitsu Kumada has published 5 paper(s) in 2006, 26 paper(s) in 2007, 6 paper(s) in 2008, for a total of 37 research publications in total.

Hiromitsu H Kumada Author Information

LAST NAME: kumada

FIRST NAME: hiromitsu

INITIALS: H

AFFILIATION:

Papers

Hiromitsu Kumada's Publication Record

1. Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients. Year Published: 2006
Department of Internal Medicine, Gastroenterology and Hepatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano-ken 390-8621, Japan.
2. Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter. Year Published: 2006
Department of Gastroenterology, Toranomon Hospital, Okinaka Memorial Institute for Medical Research, Toranomon 2-2-2, Minato-ku 105-8470, Tokyo, Japan.
3. Timing of interferon therapy and sources of infection in patients with acute hepatitis C. Year Published: 2006
Second Department of Internal Medicine, Kurume University, Fukuoka, Japan.
4. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Year Published: 2006
Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan.
5. Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels. Year Published: 2006
Kiyokawa Hospital, 2-31-12, Asagaya minami, Suginami-ku, Tokyo 166-0004, Japan.
6. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report. Year Published: 2007
Department of Hepatology, Toranomon Hospital and the Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
7. Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy. Year Published: 2007
Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
8. Interferon and lamivudine monotherapy on chronic hepatitis B in Japan. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
9. Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
10. Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
11. Successful treatment of an entecavir-resistant hepatitis B virus variant. Year Published: 2007
Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
12. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. akuta-gi@umin.ac.jp
13. A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C. Year Published: 2007
Department of Gastroenterology, University of Tokyo Graduate School of Medicine, Hongo 7-3-1, Bunkyo, Tokyo 113-8655, Japan. omata-2im@h.u-tokyo.ac.jp
14. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital.
15. Prolonged hepatitis after acute infection with genotype h hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital.
16. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan, and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
17. Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C. Year Published: 2007
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
18. Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts. Year Published: 2007
Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
19. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo. es9y-ars@asahi-net.or.jp
20. Prolonged hepatitis after acute infection with genotype H hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo.
21. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
22. Successful treatment of an entecavir-resistant hepatitis B virus variant. Year Published: 2007
Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
23. Virological Response in Patients with Hepatitis C Virus Genotype 1b and a High Viral Load : Impact of Peginterferon-alpha-2a plus Ribavirin Dose Reductions and Host-Related Factors. Year Published: 2007
Kawasaki Medical School, Kawasaki Hospital, Okayama, Japan.
24. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. akuta-gi@umin.ac.jp
25. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo. es9y-ars@asahi-net.or.jp
26. Prolonged hepatitis after acute infection with genotype H hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo.
27. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
28. Changes in viral loads of lamivudine-resistant mutants during entecavir therapy. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
29. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
30. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
31. Changes in viral loads of lamivudine-resistant mutants during entecavir therapy. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
32. A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C. Year Published: 2007
Department of Gastroenterology, University of Tokyo Graduate School of Medicine, Hongo 7-3-1, Bunkyo, Tokyo 113-8655, Japan. omata-2im@h.u-tokyo.ac.jp
33. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
34. Treatment guideline for HCV infection. Year Published: 2008
Department of Hepatology, Toranomon Hospital.
35. New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
36. New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. ZXC00701@nifty.ne.jp
37. Efficacy in patients with dose reduction in combination therapy of peginterferon and ribavirin for chronic hepatitis C. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. es9y-ars@asahi-net.or.jp